ALPEK (ALPEKA) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
27 Apr, 2026Executive summary
Achieved strong Q1 performance with comparable EBITDA of $150M, up 50% sequentially and 18-19% year-over-year, surpassing expectations due to operational readiness, improved margins, and favorable market dynamics, especially amid Middle East tensions.
Maintained steady operations globally, except for a temporary PTA site disruption in Mexico; Natural Gas business contributed incremental EBITDA, supporting overall profitability.
Advanced strategic priorities: optimized asset footprint, monetized non-strategic assets, launched growth initiatives in EPS and polypropylene, and invested in differentiated products.
CFO transition: Rodrigo Prieto Treviño to succeed José Carlos Pons as of May 1, 2026.
Financial highlights
Comparable EBITDA reached $150M, up 50% sequentially; reported EBITDA was $162M, up 133% sequentially and 24% year-over-year.
Consolidated volume reached 1.1M tons, up 9% quarter-over-quarter; total revenues were $1.69B, up 11% sequentially.
Operating free cash flow was $90M; CapEx totaled $38M, mainly for maintenance and plastics/chemicals initiatives.
Net debt stood at $1.77B, reduced by $72M sequentially; leverage improved to 3.9x from 4.4x.
Net loss attributable to controlling interest was $63M, compared to a loss of $86M in the previous quarter.
Outlook and guidance
Q2 volumes trending well; Chinese PTA margins near $300/ton, ocean freight to South America at $110/ton, and polypropylene margins expected to rise by at least $0.04/lb in April.
Expecting Q2 comparable EBITDA to reach or exceed $200M; full-year EBITDA guidance likely to hit or surpass $550M, with market volatility and geopolitical risks persisting.
Priorities: operational efficiency, financial discipline, footprint optimization, and growth opportunities.
Latest events from ALPEK
- 2026 guidance targets $450–$500M EBITDA, with deleveraging and cost controls prioritized.ALPEKA
Q4 202511 Feb 2026 - Stable volumes, $75M cost savings, and lower leverage support 2024 guidance.ALPEKA
Q2 20242 Feb 2026 - Q3 delivered record EBITDA, raised guidance, and progress on spin-off and cost savings.ALPEKA
Q3 202418 Jan 2026 - EBITDA and revenue fell YoY, but cash flow and strategic initiatives advanced.ALPEKA
Q1 202527 Dec 2025 - 2024 EBITDA beat guidance, cost savings hit $75M, and leverage improved to 2.9x.ALPEKA
Q4 202416 Dec 2025 - Lower earnings and revised guidance amid global oversupply, tariffs, and operational disruptions.ALPEKA
Q2 202516 Nov 2025 - EBITDA and cash flow rose sequentially, but oversupply and lower prices pressured guidance.ALPEKA
Q3 202523 Oct 2025